RT Journal Article
SR Electronic
T1 Deep learning based models to study the effect of glaucoma genes on angle dysgenesis in-vivo
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.12.18.21267894
DO 10.1101/2021.12.18.21267894
A1 Gupta, Viney
A1 Birla, Shweta
A1 Varshney, Toshit
A1 Somarajan, Bindu I
A1 Gupta, Shikha
A1 Gupta, Mrinalini
A1 Mahalingam, Karthikeyan
A1 Singh, Abhishek
A1 Gupta, Dinesh
YR 2021
UL http://medrxiv.org/content/early/2021/12/22/2021.12.18.21267894.abstract
AB Objective To predict the presence of Angle Dysgenesis on Anterior Segment Optical Coherence Tomography (ADoA) using deep learning and to correlate ADoA with mutations in known glaucoma genes.Design A cross-sectional observational study.Participants Eight hundred, high definition anterior segment optical coherence tomography (ASOCT) B-scans were included, out of which 340 images (One scan per eye) were used to build the machine learning (ML) model and the rest were used for validation of ADoA. Out of 340 images, 170 scans included PCG (n=27), JOAG (n=86) and POAG (n=57) eyes and the rest were controls. The genetic validation dataset consisted of another 393 images of patients with known mutations compared with 320 images of healthy controlsMethods ADoA was defined as the absence of Schlemm’s canal(SC), the presence of extensive hyper-reflectivity over the region of trabecular meshwork or a hyper-reflective membrane (HM) over the region of the trabecular meshwork. Deep learning was used to classify a given ASOCT image as either having angle dysgenesis or not. ADoA was then specifically looked for, on ASOCT images of patients with mutations in the known genes for glaucoma (MYOC, CYP1B1, FOXC1 and LTBP2).Main Outcome measures Using Deep learning to identify ADoA in patients with known gene mutations.Results Our three optimized deep learning models showed an accuracy > 95%, specificity >97% and sensitivity >96% in detecting angle dysgenesis on ASOCT in the internal test dataset. The area under receiver operating characteristic (AUROC) curve, based on the external validation cohort were 0.91 (95% CI, 0.88 to 0.95), 0.80 (95% CI, 0.75 to 0.86) and 0.86 (95% CI, 0.80 to 0.91) for the three models. Amongst the patients with known gene mutations, ADoA was observed among all the patients with MYOC mutations, as it was also observed among those with CYP1B1, FOXC1 and with LTBP2 mutations compared to only 5% of those healthy controls (with no glaucoma mutations).Conclusions Three deep learning models were developed for a consensus-based outcome to objectively identify ADoA among glaucoma patients. All patients with MYOC mutations had ADoA as predicted by the models.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding for this study was received from Indian Council of Medical Research, New Delhi (Grant no. 5/3/8/339/2017-ITR and Grant no. ISRM/12(58)/2019). DG acknowledges the funding by the Department of Biotechnology, Government of India (Grant No. BT/PR40151/BTIS/137/5/2021).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics Committee of All India Institute of Medical Sciences (New Delhi) gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authorsAIArtificial IntelligenceMLMachine LearningDLDeep learningSCSchlemm’s canalSD-OCTSpectral domain–optical coherence tomographyPCGPrimary congenital glaucomaJOAGJuvenile-onset open angle glaucomaPOAGAdult-onset primary open angle glaucomaTMTrabecular meshworkICAIridiocorneal angleIOPIntraocular pressureASOCTAnterior Segment Optical Coherence TomographyADoAAngle Dysgenesis from the ASOCTAUROCArea under receiver operating characteristic curve